Singapore markets open in 48 minutes

Straits Times Index
3,264.53
-35.51(-1.08%)
S&P 500
5,187.67
-0.03(-0.00%)
Dow
39,056.39
+172.13(+0.44%)
Nasdaq
16,302.76
-29.80(-0.18%)
Bitcoin USD
61,194.22
-1,264.29(-2.02%)
CMC Crypto 200
1,303.73
+9.06(+0.70%)

Swedish Orphan Biovitrum AB (publ) (0MTD.IL)

IOB - IOB Delayed price. Currency in SEK

Add to watchlist

282.20

0.00

(0.00%)

At close: 05:44PM BST

Loading interactive chart…

PR Newswire
Sobi has completed SEK 3 billion senior bond issue
Swedish Orphan Biovitrum AB (publ) (Sobi®) has successfully completed the inaugural issue of senior unsecured bonds of SEK 3 billion under its newly established MTN programme.
PR Newswire
Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A
Sobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of efanesoctocog alfa, for the treatment and prevention of bleeds and perioperative prophylaxis in haemophilia A. Efanesoctocog alfa is a once-weekly and high-sustained factor VIII replacement therapy for patients of all ages and any disease severity.
PR Newswire
Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024